149 related articles for article (PubMed ID: 12665899)
1. [Antiviral effect of recombinant antibody to influenza virus HA antigen].
Yang G; Wang Y; Zhao X; Han F; Wu S; Hou Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):337-40. PubMed ID: 12665899
[TBL] [Abstract][Full Text] [Related]
2. Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.
Prabakaran M; Velumani S; He F; Karuppannan AK; Geng GY; Yin LK; Kwang J
Virology; 2008 Oct; 380(2):412-20. PubMed ID: 18786689
[TBL] [Abstract][Full Text] [Related]
3. Interaction of hydrophobized antiviral antibodies with influenza virus infected MDCK cells.
Melik-Nubarov NS; Suzdaltseva YuG ; Priss EL; Slepnev VI; Kabanov AV; Zhirnov OP; Sveshnikov PG; Severin ES
Biochem Mol Biol Int; 1993 Apr; 29(5):939-47. PubMed ID: 8508145
[TBL] [Abstract][Full Text] [Related]
4. Natural influenza A virus infection of mice elicits strong antibody response to HA2 glycopolypeptide.
Kostolanský F; Mucha V; Slováková R; Varecková E
Acta Virol; 2002; 46(4):229-36. PubMed ID: 12693859
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo protection against the highly pathogenic H5N1 influenza virus by an antisense phosphorothioate oligonucleotide.
Duan M; Zhou Z; Lin RX; Yang J; Xia XZ; Wang SQ
Antivir Ther; 2008; 13(1):109-14. PubMed ID: 18389905
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge.
Liu W; Zou P; Chen YH
Immunol Lett; 2004 May; 93(2-3):131-6. PubMed ID: 15158608
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.
Isaka M; Zhao Y; Nobusawa E; Nakajima S; Nakajima K; Yasuda Y; Matsui H; Hasegawa T; Maeyama J; Morokuma K; Ohkuma K; Tochikubo K
Microbiol Immunol; 2008 Feb; 52(2):55-63. PubMed ID: 18380802
[TBL] [Abstract][Full Text] [Related]
8. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
[TBL] [Abstract][Full Text] [Related]
9. Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection.
Mozdzanowska K; Maiese K; Furchner M; Gerhard W
Virology; 1999 Feb; 254(1):138-46. PubMed ID: 9927581
[TBL] [Abstract][Full Text] [Related]
10. A protective immune response in mice to viral components other than hemagglutinin in a live influenza A virus vaccine model.
Horimoto T; Takada A; Iwatsuki-Horimoto K; Kawaoka Y
Vaccine; 2004 Jun; 22(17-18):2244-7. PubMed ID: 15149783
[TBL] [Abstract][Full Text] [Related]
11. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus.
Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL
Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703
[TBL] [Abstract][Full Text] [Related]
12. Effects of antibody to the influenza A virus M2 protein on M2 surface expression and virus assembly.
Hughey PG; Roberts PC; Holsinger LJ; Zebedee SL; Lamb RA; Compans RW
Virology; 1995 Oct; 212(2):411-21. PubMed ID: 7571410
[TBL] [Abstract][Full Text] [Related]
13. IgG neutralization of type A influenza viruses and the inhibition of the endosomal fusion stage of the infectious pathway in BHK cells.
Outlaw MC; Dimmock NJ
Virology; 1993 Aug; 195(2):413-21. PubMed ID: 8337821
[TBL] [Abstract][Full Text] [Related]
14. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.
Huleatt JW; Nakaar V; Desai P; Huang Y; Hewitt D; Jacobs A; Tang J; McDonald W; Song L; Evans RK; Umlauf S; Tussey L; Powell TJ
Vaccine; 2008 Jan; 26(2):201-14. PubMed ID: 18063235
[TBL] [Abstract][Full Text] [Related]
15. Two doses of parenterally administered split influenza virus vaccine elicited high serum IgG concentrations which effectively limited viral shedding upon challenge in mice.
Hovden AO; Cox RJ; Madhun A; Haaheim LR
Scand J Immunol; 2005 Oct; 62(4):342-52. PubMed ID: 16253121
[TBL] [Abstract][Full Text] [Related]
16. Comparison of monoclonal antibodies with ferret sera for the characterization of influenza A (H3N2) virus strains in a computer system.
Osterhaus AD; Weijers TF; Bijlsma K; de Ronde-Verloop FM; van Asten JA; de Jong JC
Dev Biol Stand; 1984; 57():245-50. PubMed ID: 6526140
[TBL] [Abstract][Full Text] [Related]
17. Development and application of monoclonal antibodies against avian influenza virus nucleoprotein.
Yang M; Berhane Y; Salo T; Li M; Hole K; Clavijo A
J Virol Methods; 2008 Feb; 147(2):265-74. PubMed ID: 18006085
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody, but not synthetic peptide, targeting the ectodomain of influenza B virus M2 proton channel has antiviral activity.
Wang Y; Xu H; Wu N; Shi H; Wang X; Wang T
New Microbiol; 2010 Oct; 33(4):311-7. PubMed ID: 21213589
[TBL] [Abstract][Full Text] [Related]
19. Biochemistry. Catching a moving target.
Wang TT; Palese P
Science; 2011 Aug; 333(6044):834-5. PubMed ID: 21836007
[No Abstract] [Full Text] [Related]
20. Enhanced protective immunity against H5N1 influenza virus challenge by vaccination with DNA expressing a chimeric hemagglutinin in combination with an MHC class I-restricted epitope of nucleoprotein in mice.
Tao P; Luo M; Pan R; Ling D; Zhou S; Tien P; Pan Z
Antiviral Res; 2009 Mar; 81(3):253-60. PubMed ID: 19135483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
